Download Conference Summary

Co hosted by:

October 26-28, 2016São Paulo, Brazil

Strategic Partner:

-1-

By the Numbers

Why Attend• GAIN UNPARALLELED ACCESS to life science, industrial, biochemical and

environmental products and technologies from across Latin America

• Be at the forefront of the LATEST INDUSTRY INNOVATIONS

• Arrange UNLIMITED FACE-TO-FACE MEETINGS with high-value potential partners

• Learn about the venture capital industry and other FUNDING POSSIBILITIES IN LATIN AMERICA

• ENGAGE LOCAL GOVERNMENT BODIES, RESEARCH CENTERS, INDUSTRY CLUSTERS AND COMPANIES that will help you to succeed in the Latin America life sciences market

577 Attendees 28 Countries

Represented 23 Company/Startup Presentations 18 Plenaries

& Sessions

318 Companies Attended625 15 Investors

www.bio.org/latinamerica

-2-

Who Attends

Areas of Focus

BREAKDOWN BY DELEGATE TYPE

24%Biopharmaceuticals

17%Industrial & Environmental, Food & Ag & Animal Health9%

Academic, Tech Transfer & Research Center

17%Government, Economic

Development & Association

5%Investors &

Investment Bank

7%Other (Media, Engineering, Supplier, etc.)

4%CMO and CRO

3%Medical Device,

10%Consulting & Legal

4%Digital Health & Information Technology 25%

C-Level(CEO, CFO, President, Vice-President, Partner, etc.)

45%

30%Other (Coordinador, Analyst, etc.)

Animal HealthHuman HealthMarket Opportunities

Intellectual PropertyHuman CapitalInternational Cooperation


-3-

2016 Advisory Committee

Fred AslanVice President, Venrock Associates / Board Member, BayBrazil (USA)

Reginaldo ArcuriPresident, Grupo FarmaBrasil (Brazil)

Bernardo SilvaExecutive President, Brazilian Industrial Biotechnology Association (ABBI), (Brazil)

Rodrigo Correa-OliveiraPartner and Researcher, Nanomark and Oncologics (Brazil)

Andrea Carla Barreto CunhaonDirector of Technical Affairs, ABIQUIM

Meredith FensomDirector, Government Affairs, Intrexon (USA)

Pedro Luiz FernandesVice President of Corporate Affairs & Sustainability, Latin America, Novozymes

Antonio BrittoPresident, Interfarma

Christophe LuguelInternational Affairs Manager, Competitiveness Cluster Industries & Agro-Ressources (IAR), (France)

Jaime FinguerutIndustrial Strategic Development, Sugarcane Technology Center (CTC), (Brazil)

Gabriel Di BlasiPartner, Di Blasi, Parente & Associados (Brazil)

Alan VanderborghtManaging Director & Chief Executive Director, Kybora (Mexico)

Cristián HernándezChief Operting Officer, Andes Biotechnologies (Chile)

Ana Laura LopesDirector of BD for Physical Sciences, Boston University / Board Member, SciBr Foundation (USA)

Jorge KalilDirector, Butantan Institute (Brazil)


-4-

Schedule of Events

Wednesday, October 26, 2016 10:00 - 12:00 Oxitec Inauguration of First Large Scale Factory

14:00 - 19:00 Early Check-in & Registration

14:00 - 17:00Pre-Conference SeminarRegenerative Medicine & Cell Therapy: A New Paradigm in Human Health

17:00 - 19:00 Welcome Reception

Thursday, October 27, 2016 08:00 - 18:00 Check-in & Registration

08:30 - 09:00 Welcome Address

09:00 - 10:30 Opening Plenary: The Value of the Bioeconomy

10:30 - 10:45 Coffee Break

10:30 - 17:45 One-on-One Partnering™ Meetings (Scheduled in 30-min-ute intervals)

10:45 - 12:00I&E Leadership Session: Building a Successful In-dustrial Biotech Start-Up

Health Leadership Session: Overview of Critical Trends Affecting the In-novative Industry in Latin America

10:45 - 12:00 Company Presentations (15-minute timeslots)

12:00 - 13:30 Buffet Lunch Break

12:00 - 14:30 Minas Lunch Seminar

13:30 - 14:45I&E Leadership Session: Biorefinery Scale-Up Challenges

Health Leadership Session: Regulation of Biological Medicines in Brazil


14:45 - 16:00

I&E Leadership Session: Food & Cosmetic Ingredi-ents Boosted by Biotech-nology

Health Leadership Ses-ssion: Innovative Entrepre-neurship and Corporate Venture


16:30 - 17:45I&E Leadership Session: Synthetic Biology- Technol-ogy for the Future

Health Leadership Session: Public-Private Partner-ships: How to Prevent and Solve Epidemics and Pandemics from Dengue to Zika


18:00 - 20:00 Networking Reception

Friday, October 28, 2016 08:00 - 12:00 Check-in & Registration

09:00 - 10:15

I&E Leadership Session: Regulatory Barriers to Growing the Bio-Based Economy

Health Leadership Ses-ssion: Genetic Medicines Come of Age: The Challenges and Opportunities


09:00 - 16:00 One-on-One Partnering™ Meetings (Scheduled in 30-min-ute intervals)


10:45 - 12:00

I&E Leadership Session: The Role for Academia in a Growing Bio-Based Economy

Agricultural Biotech Spot-light Session How the Biotech Revolu-tion is Transforming Crop Protection


12:00 - 13:30 Buffet Lunch Break

13:30 - 14:45 I&E Leadership Session: Industrial Property in the Latin America Market

13:30 - 16:00 BioStartup Lab Arena (8-minute timeslots) Supported by ABDI

13:30 - 14:00Fireside Chat:Rogerio Ribeiro, Senior Vice President, Emerging Mar-kets and Asia Pacific, GlaxoSmithKline (GSK)

14:00 - 14:45Health Leadership Session: Trends in Emerging Therapeutic Company Deal-Making and R&D Productivity

14:30 - 15:30

I&E Leadership Session: Below50: Growing the Global Market for Sustain-able Fuels

Health Leadership Session: The Future of Biothera-peutics in Latin America: From Biossimilars to Innovative Products

16:00 - 16:15 Farewell Coffee Break


-5-

Plenary Sessions

Pre-Conference Seminar - Regenerative Medicine & Cell Therapy: A New Paradigm in Human HealthRegenerative medicine represents a new paradigm in human health, with the potential to solve unmet medical needs, addressing the underlying causes of diseases. Regenerative medicine and cell therapy harness the power of stem cells, tissue engineering and biomaterials to repair, regenerate or replace cells, tissues and organs. These technologies have the potential to treat, control and possibly cure some of the most debilitating and costly diseases in the world today, such as heart diseases and diabetes. This pre-conference plenary will bring regional experts to discuss challenges and present success cases on this subject.

Speakers: • Patricia Beltrão, Professor, Universidade de São Paulo (USP)• Hugo Cabrera, Business Development Director, Cellus Medicina Regenerativa• Renata Miranda Parca, Specialist, Department of Blood, Tissues, Cells and Organs, Agência Nacional de Vigilância

Sanitária (ANVISA)• Graciela Pignatari, Executive Director, Tismoo*• Marcos Valadares, Co-founder, Pluricell• Douglas Valverde, Chief Executive Officer & President, Techtrials

Welcome AddressSpeakers:

• Eduardo Emrich, President and Chief Executive Officer, Biominas Brasil• Jim Greenwood, Chief Executive Officer, BIO• Bernardo Silva, Executive President, ABBI

Opening Plenary: “The Value of the Bioeconomy”Our distinguished panelists will discuss the value of biotech innovation to society and explore the strengths and opportunities that exist in Latin American to drive innovation forward. What makes the region so attractive? Why focus on biobased solutions now? Our dynamic speakers will seek to answer these questions. Topics to include value of innovation in health, the cost competitiveness of biomass in the region, the creation of value added products such as fine and specialty chemicals, fuels, and processes, and investments in biobased technologies.

Moderator: Jim Greenwood, Chief Executive Officer, BIOSpeakers:

• Igor Bueno, Superintendent of the Health, Agribusiness and Chemicals Department, Brazilian Innovation Financing Agency (FINEP)*

• Marco Antonio Fireman, Secretary of Science, Technology and Strategic Inputs, Ministry of Health• Bernardo Gradin, Chief Executive Officer, GranBio • Hadyn Parry, Chief Executive Officer, Oxitec• Luiz Otávio Pimentel, President, Brazilian Patent and Trademark Office (INPI) • Marcos Vinicius de Souza, Secretary of Innovation, Ministry of Industry, Foreign Trade and Services (MDIC)


-6-

Plenary Sessions

Minas Lunch SeminarGrand Hyatt São Paulo / Room Aurum – Av. Nações Unidas, 13301 – Vila Cordeiro, São Paulo/SP

The Federation of Industries of the State of Minas Gerais (FIEMG), in cooperation with Biominas Brasil, invites you to attend the lunch seminar Invest in Minas that will be held at the BIO Latin America Conference. Your company will be introduced to the best investment opportunities in the State, the existing ecosystem of Biotechnology in Minas Gerais and how the government can help investors that want to settle their companies there.

12:00 pm: Welcome Network Lunch12:30 pm: Presentations

• Eduardo Emrich, CEO, Biominas Brasil• Guilherme Emrich, President of the Advisory Board, Biominas Brasil• Marcos Mandacaru, Strategic and International Affairs of Strategic Priorities Office, FIEMG• Cristiane Serpa, President, The Integrated Development Institute of Minas Gerais (INDI)• Marcos Vinicius de Souza, Secretary of Innovation, Ministry of Industry, Foreign Trade and Services (MDIC)

1:30 pm – 2:30pm: Questions and Answers + One-on-One meetings


-7-

Industrial and Environmental Leadership Sessions

Building a Successful Industrial Biotech Start-UpStartup companies will discuss exciting new technologies, and how to bring these technologies to market, in addition to highlighting the role of venture funding, collaborations and key partnerships, and the lessons learned in the challenges to scale.

Moderator: Fernando Reinach, Managing Partner, Fundo Pitanga Speakers:

• Marcelo do Amaral, PhD, Chief Executive Officer, GlobalYeast • Sérgio Robles Reis de Queiroz, Special Advisor to the Scientific Director, São Paulo Research Foundation

(FAPESP)• Marcio Schittini, Director, EcoMetano

Biorefinery Scale-Up ChallengesOur panelists will discuss the challenges faced in scaling up biorefineries, what is driving companies to commercialize second generation feedstocks, and what lessons have been learned along the way.

Moderator: Luciano Cunha de Sousa, New Business Coordinator, Secretariat of Innovation, Ministry of Industry, Foreign Trade and Services (MDIC)Speakers:

• Carlos Eduardo Cavalcanti, Head of Biofuels Department, The Brazilian Development Bank (BNDES)• Eduardo Loosli, Vice President, Pilot Plant, Amyris• Thomas Mallet, Technology Development Manager, Axens • Antonio Alberto Stuchi, Director, Raizen

Food & Cosmetic Ingredients Boosted by BiotechnologyOur panelists will discuss the importance of using biotechnology to boost their competitiveness in international markets.

Moderator: Bruno Brasil, PhD, R&D Assitant Director, Embrapa AgroenergySpeakers:

• Adrian Martin Pohlit, General Coordinator of the Amazon Biotechnology Center (CBA) and Researcher of the National Institute of Amazonian Research (INPA)

• Roberta Roesler, PhD, Research & Development Manager, Natura • Daniel Sabara, Chief Executive Officer, Beraca• Bruno Sato, Performance Materials, International Raw Material Department, L’Oréal


-8-

Synthetic Biology- Technology for the FutureWhat are the technologies for the future? How will the implications of synthetic biology impact the growth in this sector? Our panelists will demonstrate the impact of synthetic biology.

Moderator: Paulo Coutinho, PhD, Director, SENAI Innovation Institute in BiosyntheticSpeakers:

• John Biggs, Research & Development, Director Latin America, Dow• Bernard Chaud, Vice President of Industrial Strategy, Global Bioenergies• Mateus Schreiner Garcez Lopes, PhD, Innovation in Renewable Technologies, Manager, Braskem

Regulatory Barriers to Growing the Bio-Based EconomyThis session will focus on regulatory hurdles faced by the industrial biotech sector specifically with regard to biological diversity and the biological diversity legal framework.

Moderator: Thiago Falda, Director of Regulatory Affairs, Brazilian Industrial Biotechnology Association (ABBI)Speakers:

• Pedro Luis Fernandes, Vice President of Corporate Affairs & Sustainability for Latin America, Novozymes• Rafael Marques, Head Of CGEN, Ministry Of Environment, Brazil• Anita Pissolito, Partner, Nascimento Mourão Advogados• Thiago Terada, Head of Sustainability, Beraca

The Role for Academia in a Growing Bio-Based EconomyOur panelists will discuss the relationship between academics and the business community, identify disconnects between the two, highlight the status of bioscience, and talk about academic partnerships to advance industrial bioscience.

Moderator: Christophe Luguel, Head of International Affairs, Cluster Industries & Agro-resources (IAR)Speakers:

• Wilson Araujo, PhD, Science Technology & Innovation Corporate Advisor, Brazil• José Vitor Bomtempo, PhD, Professor of the Chemicals School, Universidade Federal do Rio de Janeiro• Jaime Finguerut, Industrial Strategic Development, Centro De Technologia Canavieira (CTC)• Gonçalo Amarante Guimarães Pereira, PhD, Chief Scientific Officer, GranBio



-9-

Industrial Property in the Latin America MarketPanelists will discuss new industrial property laws in Latin America, and how these laws affect the growth of the industrial biotechnology sector in the region.

Moderator: Gabriel Di Blasi, Partner, Di Blasi, Parente & AssociadosSpeakers:

• Laura Hammel, Intellectual Property Attaché for Mercosur, Guianas, and Suriname, U.S. Commercial Service• Matthew McBride, Manager, Science IP, Chemical Abstracts Service• Júlio César Moreira, Director of Patents, Instituto Nacional da Propriedade Industrial (INPI)• Raquel Rinke, Laboratory Manager, Royal DSM

Below50: Growing the Global Market for Sustainable FuelsBelow50 aims to reframe the old perception of low carbon fuels, and help create the conditions for their successful development and commercialization. Our speakers will discuss how to create cross-sectoral business opportunities in new and mature markets, highlight the importance of working with government to promote public private partnerships and join initiatives, and expand upon Below50 as the global, unified voice for sustainable fuels.

Moderator: Gerard Ostheimer, Global Lead, Sustainable Bioenergy Group, Sustainable Energy For All (SE4ALL)Speakers:

• José Guilherme Nogueira, Chief Executive Officer , Socicana• Aurea Nardelli, Regional Director of Business Development, South America, Roundtable on Sustainable

Biomaterials (RSB)• Pedro Scorza, Director of Technical Operations, Gol Airlines • Atul Thakrar, President, DSM Bio-based Products & Services• Emerson de Vasconcelos, Regional President LatAM, Novozymes



-10-

Overview of Critical Trends Affecting the Innovative Industry in Latin AmericaThe research and development of innovative products in the biotechnology space is an increasingly international endeavor, which requires the close coordination and collaboration of experts from diverse sectors around the globe. Esteemed industry, government and finance experts will share their views on global partnerships and research projects in healthcare throughout Latin America.

Moderator: David Thomas, Senior Director, Industry Research and Policy Analysis, BIOSpeakers:

• Paulo Braga, Group Vice President, Clinical & Medical Affairs for Latin America, Genzyme/Sanofi• Rafael Henrique Rodrigues Moreira, Director, Department of Innovative Technologies, Ministry of Industry,

Foreign Trade and Services (MDIC)*• João Sanches, Senior Advisor, Albright Stonebridge Group

Regulation of Biological Medicines in BrazilA panel with ANVISA experts to discuss the regulatory environment for biological products in Brazil and to discuss the role of the regulatory agency in helping to spur economic growth in the sector.

Speakers:• Márcia Gonçalves de Oliveira, Manager, Department of Pharmacovigilance, Agência Nacional de Vigilância

Sanitária (ANVISA)• Gustavo Mendes Lima Santos, Coordinator, Therapeutic Equivalence, Agência Nacional de Vigilância Sanitária

(ANVISA) • José Carlos Moutinho, Director, Sanitary Monitoring and Control, Agência Nacional de Vigilância Sanitária

(ANVISA)• Fanny Nascimento Moura Viana, Specialist, Department of Clinical Trials, Agência Nacional de Vigilância Sanitária

(ANVISA)• Vanessa Lucas Xavier, Specialist, Department of Biologics Products, Agência Nacional de Vigilância Sanitária

(ANVISA)

Innovative Entrepreneurship and New Ventures Paradigms that Accelerate and BoostIncreasingly across Latin America and specifically in Brazil, companies/institutions with innovation strategies are gaining assistance in their endeavors from national institutions and other sources. To spur entrepreneurship for start-ups and other firms engaged in the commercialization of innovative products, companies and institutions are gaining assistance from venture capitalists, foundations, pharmaceutical companies and entrepreneurs who serve as mentors, advisers, funders and more. This session will highlight this increasing trend.

Moderator: Eduardo Emrich, President & Chief Executive Officer, Biominas BrasilSpeakers:

• Bob Blouin, Dean, University of North Carolina, Eshelman School of Pharmacy• João Paulo Pieroni, Head of Intermediary Products, Chemicals and Pharmaceuticals Department, The Brazilian

Development Bank (BNDES)• Claudio Terra, Director of Innovation and Knowledge Management, Hospital Albert Einstein• Pedro Waengertner, Chief Executive Officer, ACE & President, Associação Brasileira de Empresas Aceleradoras

de Inovação e Investimento (ABRAII)

Human Health Leadership Sessions


-11-


Public-Private Partnerships: How to Prevent and Solve Epidemics and Pandemics from Dengue to ZikaThis session will focus on advancements in the diagnosis and treatments of these diseases. In addition to companies working in this space, the panel will discuss activities undertaken at the international organizational level with a particular focus on the WHO’s research and development blueprint for action to prevent epidemics which was presented to Member States at the World Health Assembly in May 2016.

Moderator: Mariana Lenharo, Reporter, Portal G1, Globo NetworkSpeakers:

• Paulo Paes de Andrade, Professor, Universidade Federal de Pernambuco • Gabriel Ferrato, Mayor, Piracicaba (SP)• Marcelo de Franco, Vice Director, Innovation and Development, Butantan Institute• Luiz Reis, Superintendent of Research & Development, Hospital Sirio-Libanes

Genetic Medicines Come of Age: The Challenges and OpportunitiesThe field of medical genetics continues to open new opportunities in diagnosis, management and counselling of patients with genetic disorders. While areas such as gene therapy, personalized medicine and predicative medicine continue to rapidly improve our understanding and ability to treat to genetic disorders, we still face many challenges in this space. This session will cover opportunities and challenges in personalized health and molecular diagnostics and the contributions that the world can expect from Latin America.

Moderator: Eduardo Emrich, President & Chief Executive Officer, Biominas BrasilSpeakers:

• Bruno Soares, Chief Executive Officer, Coimbra Genomics• Emmanuel Dias-Neto, Head of Medical Genomics, A.C.Camargo Cancer Center• Xavier Soberón Mainero, General Director, Instituto Nacional de Medicina Genómica (INMEGEN)• Patricia Munerato, Executive Director of Genetic Science and Clinical Division, Thermo Fisher Scientific for

Latin America

How the Biotech Revolution is Transforming Crop ProtectionPanelists will focus on the benefits biotechnology brings to agriculture and the world through enabling sustainable food production. Revolutionary, environmentally friendly crop protection technologies will be discussed.

Moderator: Paula Carneiro, Director, Céleres* Speaker:

• Sekhar Boddupalli, President, Intrexon Crop Protection• Adalecio Kovaleski, Researcher, Embrapa


-12-

Trends in Emerging Therapeutic Company Deal-Making and R&D ProductivityThe ability to access capital and form strategic alliances is vital for small therapeutic-focused companies to succeed in translating novel drug candidates into approved medical products for patients. BIO's David Thomas will be presenting trends seen in deal-making and R&D over the last decade. The state of venture funding, public investment (IPOs and follow-ons), licensing, and M&A will include a cross-sectional analysis by major disease areas. An investigation into R&D productivity will cover the largest study ever on clinical trial success rates. The analysis, conducted in collaboration with Biomedtracker, will cover ~10,000 clinical program transitions from 2006-2015. Individual therapeutic areas will be examined, as well as answers to long held questions: Do selection biomarkers yield higher success? Are rare disease programs experiencing higher success rates? Are biologics R&D programs more successful than small molecule programs?

Speaker:• Dave Thomas, Senior Director, Industry Research and Policy Analysis, BIO

The Future of Biotherapeutics in Latin America: From Biosimilars to Innovative ProductsThis panel will focus on the opportunities in Latin America to contribute towards the development of innovative biologics. The infrastructure for pre-clinical and clinical studies will be reviewed, as well as the role of universities and the private sector in helping to translate basic research to more advanced projects. Perspectives from patient advocacy groups and from the investment community will also be shared.

Moderator: Gustavo de Freitas Morais, Partner, Danneman SiemsenSpeakers:

• Ricardo Garcia, Director, CLAPBio• Marité Prieto, Regulatory Affairs Director, Amgen• Rodrigo Silvestre, Director of the Department of Health and Innovation Industrial Complex, Secretariat of

Science, Technology and Strategic Inputs, Ministry of Health• Priscila Torres, President, BIORED Brasil

Fireside ChatRogerio Ribeiro, Senior Vice President & Area Head Emerging Markets and Asia Pacific, GlaxoSmithKlineModerator: Justin Duarte Pine, Director, International Affairs, BIOSpeaker: Rogerio Ribeiro, Senior Vice President, Emerging Markets and Asia Pacific, GlaxoSmithKline (GSK)



-13-

Presenting Companies

15-minute presentations are given back-to-back throughout the three-day conference and showcase a company's pipeline, R&D activities, business and partnering objectives and investment goals.

Company Country

AcelRx Pharmaceuticals, Inc. United States

Biocubafarma Group Cuba

BIOMM SA United States

BrazilCelgene United States

Coimbra Genomics Portugal

GC-2 Gestão do Conhecimento Cientifico SA Brazil

ILS Clinical Research Mexico

InKemia Spain

Intrexon United States

Onconova Therapeutics, Inc. United States

Oxitec Ltd United Kingdom

Sanofi/Genzyme United States

S2G Biochemicals Inc. Canada

Sidetech Brazil

Thomson Reuters IP&Science United States


-14-

Registration

For registration rates visit bio.org/latinamerica or email [email protected] Latin America welcomes delegations from countries, regions, states, provinces, biotech clusters, and industry associations. We can work with you to develop attendee benefits tailored to your specific needs:

Discounted registration fees for all members of the delegation;

Opportunity to submit a full color advertisement in conference handbook;

Add a delegation document into the conference handbag;

Pre-conference promotion via the conference website and newsletters;

Inclusion of promotional materials on shared literature table strategically located in the networking area.

Special delegation pricing is available, please contact:

For Latin America Delegation inquiries:Letícia Farias Biominas Brasil Phone: 55 (31) 3303-0020 Email: [email protected]

For North America, Europe and Rest of World Delegation inquiries:Diana DeJoy Biotechnology Innovation Organization Phone: (202) 962-4679 Email: [email protected]

Hotel/Venue InformationGrand Hyatt São PauloAddress: Avenida das Nacoes Unidas 13.301, Sao Paulo, Brazil, 04578-000Phone:+55 11 2838 1234Website: http://saopaulo.grand.hyatt.com/en/hotel/home.htmlBook your room today to also receive the discounted room rate. Reservation requests are based on availability, space is limited.

3

3

3

3

3


2016 SponsorsPremium Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors

Conference Sponsors

Contact us today for a tailored sponsorship package that will meet your business objectives. Please contact:Fabien Rabanal at [email protected] and (202) 312-9278.For more information on BIO sponsorships, please visit www.bio.org/sponsor

2016 SponsorsMedia PartnersConference Supporters

Documents

Download Conference Summary